Rituximab maintenance improves overall survival in follicular lymphoma: A retrospective nationwide real‐world analysis from Taiwan Cancer Registry Database

Follicular lymphoma (FL) is the most frequent indolent lymphoma in Western countries, but it is less frequent in Asia. Several trials have demonstrated the progression‐free benefit of rituximab maintenance for FL patients in Western countries. However, the overall survival (OS) benefits and effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Huai‐Hsuan, Wen, Yao‐Chun, Chen, Ho‐Min, Hsiao, Fei‐Yuan, Ko, Bor‐Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089160/
https://www.ncbi.nlm.nih.gov/pubmed/30009424
http://dx.doi.org/10.1002/cam4.1622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089160/
https://www.ncbi.nlm.nih.gov/pubmed/30009424
http://dx.doi.org/10.1002/cam4.1622

Ejemplares similares